Gartner: Q2 Earnings Insights

  Gartner (NYSE:IT) reported its Q2 earnings results on Tuesday, August 2, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Earnings Gartner beat estimated earnings by 33.8%, reporting an EPS of $2.85 versus an estimate of $2.13.

 

Gartner (NYSE:IT) reported its Q2 earnings results on Tuesday, August 2, 2022 at 06:00 AM.

Here’s what investors need to know about the announcement.

Earnings

Gartner beat estimated earnings by 33.8%, reporting an EPS of $2.85 versus an estimate of $2.13.

Revenue was up $210.00 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.58 which was followed by a 0.38% drop in the share price the next day.

Here’s a look at Gartner’s past performance:

 

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate 1.75 2.42 1.56 1.73
EPS Actual 2.33 2.99 2.03 2.24
Revenue Estimate 1.24B 1.25B 1.13B 1.12B
Revenue Actual 1.26B 1.31B 1.16B 1.17B

To track all earnings releases for Gartner visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Curated Strains And Branded Cannabis Gear By The Cannabist And Revelry Launching In Four East Coast Markets

The Cannabist Company Holdings Inc. is expanding its partnership with Revelry Herb Co., an artisan-quality flower and pre-roll brand launched by the creators of Revelry Supply. The expansion into the Maryland, Ohio, Pennsylvania and New York markets follows a recent collaboration in New Jersey and Massachusetts, Jesse Channon, president of The Cannabist Company, said. "We've experienced remarkable success with Revelry in just a short amount of time since launching in New Jersey and Massachusetts and the feedback we are getting from our patients and customers has been off the charts," Channon said. "We are especially honored to be their trusted cultivation, production and manufacturing partner delivering top-quality flower strains from our facilities across all our markets for this expansion."

CBSTF